Optorhythm

Optogenetic therapy for the Treatment of Atrial Fibrillation with an Implantable Optic

Health Tech & Life Sciences
Non Active, Jul 2025 ceased to operate
Pre-Seed Israel Founded 2024
LinkedIn
Last updated 2026-06-18
Total raised
Last: 2024-09
Stage
Pre-Seed
Founded
2024
Headcount
1
HQ
Israel
Sector
Health Tech & Life Sciences

About

OptoRhythm is developing a novel light-based method for controlling heart rhythms. Built on over 20 years of research by Prof. Lior Gepstein, a leader in cardiac electrophysiology and optogenetics, OptoRhythm’s approach aims to improve treatment for Atrial Fibrillation (AF). The technology integrates optogenetic gene therapy with an implantable micro-LED array to create the first Optic Defibrillator, designed to stop chaotic atrial contractions through targeted light pulses, offering an alternative to traditional electric shocks. This real-time, repeatable, and non-destructive approach addresses limitations in existing AF treatments, aiming for sustained rhythm control and improved patient outcomes.

Funding history · 1 round · — total

2024-09
Undisclosed

Q&A

What is Optorhythm's primary focus?
Optorhythm is developing an optogenetic therapy for the treatment of Atrial Fibrillation (AF) using an implantable optic, aiming to control heart rhythms with light-based methods.
When was Optorhythm founded?
Optorhythm was founded in August 2024.
What is the current status of Optorhythm?
Optorhythm is currently inactive, having ceased operations in July 2025.
Who is the co-founder and CEO of Optorhythm?
Yaki Eidelstein is the Co-founder and CEO of Optorhythm.
What is Optorhythm's employee count?
Optorhythm has 1-10 employees.
Which investor participated in Optorhythm's funding round in September 2024?
NGT HealthCare II participated in Optorhythm's funding round in September 2024.
What is the product stage of Optorhythm's technology?
Optorhythm's technology is in the research and development (R&D) stage.
What sector does Optorhythm primarily operate in?
Optorhythm primarily operates in the Health Tech & Life Sciences sector.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders

Tags

healthcarecardiology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/105463860

Identifiers & details

Founded2024-8
Employees (exact)1
Status reasonNon Active, Jul 2025 ceased to operate